Rezdiffra (Resmetirom) Black / African Ancestry Dose Adjustments
A clinical deep-dive into resmetirom dosing, pharmacogenomics, and efficacy data for Black and African ancestry patients with NASH/MASH, including ethnicity-stratified MAESTRO-NASH subgroup analysis and CYP2C8/OATP1B1/G6PD pharmacogenomic considerations.
Read clinical review